show episodes
 
Artwork

1
PBM on the Rocks

Pharmacists United for Truth & Transparency

Unsubscribe
Unsubscribe
Månedligt
 
It's time to break the ice on pharmacy benefit managers' "drink the Kool-Aid" rhetoric! Join Pharmacists United for Truth & Transparency as we host guests from across the healthcare industry to discuss pharmacy news, healthcare issues, & (of course) PBMs... over cocktails.
  continue reading
 
Artwork

1
HR Benecast

Employers Health: Group Purchasing for Pharmacy Benefits

Unsubscribe
Unsubscribe
Månedligt
 
Join Employers Health's Chief Strategy Officer, Mike Stull, for our podcast on all things HR and employee benefits related. We'll cover your most frequently asked human resource questions, benefits best practices, our unique employer-led group purchasing program for pharmacy benefits management and more. We want this to be your podcast, with content that is relevant to you and your organization. Therefore, we invite you to submit questions or topics of interest that you would like covered in ...
  continue reading
 
Welcome to PBM Unplugged, the podcast that takes you behind the scenes of the pharmacy benefit management industry. Join us as we delve into strategies, insider tips, and expose corruption within the world of prescription drug benefits. We aim to empower employers, providers, and payers with the knowledge they need to navigate this complex landscape effectively. Get ready to uncover the truth and gain valuable insights on maximizing prescription drug benefits. This is PBM Unplugged. Together ...
  continue reading
 
Healthcare innovations that make a difference. On the show, Cristy Gupton, President of Custom Benefits Solutions, meets with other experts in the industry and talks over solutions to current obstacles. Today's problems with healthcare and how we change it for the better.
  continue reading
 
The Off Script podcast offers in-depth interviews and discussions with industry experts about hot-button topics in pharma, and goes behind the scenes of Pharma Manufacturing’s print and online coverage, which follows the industry’s biggest issues surrounding scale-up, technology innovations, regulations and more
  continue reading
 
American Healthcare Entrepreneurs and Execs you might want to know. Talking. Relentless Health Value is a weekly interview podcast hosted by Stacey Richter, a healthcare entrepreneur celebrating fifteen years in the business side of healthcare. This show is for leaders in pharma, devices, payers, providers, patient advocacy and healthcare business. It's for health industry innovators, entrepreneurs or wantrepreneurs or intrapreneurs. Relentless Healthcare Value is the show for you if you wan ...
  continue reading
 
Independent pharmacies are the last line of defense between patients and a pharmacy system that is quickly becoming a monopoly. The Independent Pharmacy Alliance Podcast will explore why Americans pay the highest drug prices in the world, highlight the life-saving services independent pharmacies provide, and how Pharmacy Benefit Managers utilize anti-competitive business practices to increase drug prices. In each episode, we‘ll talk to a pharmacist or front-line worker fighting for patients ...
  continue reading
 
Healthcare is Hard: A Podcast for Insiders views healthcare transformation through the lens of prominent leaders across the industry. Through intimate one-on-one discussions with executives, policy advisors, and other “insiders,” each episode dives deep into the pressing challenges that come with changing how we care for people. Hear the unique perspectives of these industry leaders to get a better understanding of what is happening today, the challenges across the healthcare ecosystem, and ...
  continue reading
 
Artwork

1
NFP's Insights from the Experts

NFP's Insights from the Experts

Unsubscribe
Unsubscribe
Månedligt
 
NFP introduces the Insights from the Experts podcast series. Each episode will showcase timely perspective from members of the NFP community, delivering information, analysis and solutions that address our clients’ most significant challenges. You can find archived episodes of Innovation Conversations at https://soundcloud.com/user-939810789.
  continue reading
 
JC Scott, President & CEO of the Pharmaceutical Care Management Association, discusses the latest trends, public policy developments, and political challenges impacting drug pricing and healthcare. You'll hear the nation's top thought leaders, policy experts, and political analysts on topics like how employers, unions, and others use Pharmacy Benefit Managers (PBMs) to drive value for their members in the face of growing healthcare costs. You'll also learn about advancements in gene therapy, ...
  continue reading
 
Loading …
show series
 
Grab and drink & join this month's very special cocktail crew as they discuss the many reasons why this September's Friday the 13th protest at OptumRx is so important, and how raising your voice about the issues is crucial for advocating across the healthcare spectrum. Special Guests: Angry Dad Bil Schmidtknecht (@angrydadwi), AIDS Healthcare Found…
  continue reading
 
Chris is an incredible guy. He tells an amazing story about his journey following a blood cancer diagnosis. Chris faced the news at one point that he may only have 6 months to live but beat the odds and is now all clear and in full health. Chris is yet another cancer survivor that has gone on to do some incredible work, helping others. Chris set up…
  continue reading
 
First of all, we got two really nice reviews lately. One is from Doug Geinzer. Hi, Doug! Doug wrote, “[Relentless Health Value is] a must listen. There are just a few podcasts that I listen to religiously [and] Relentless Health Value is one of those.” He goes on to say we have a knack for “finding the brightest of the bright and asking the right q…
  continue reading
 
So, after some pondering, I decided to release this conversation with Shawn Gremminger about 340B in two parts. So, listen to one, listen to both, pick your poison. Shawn Gremminger came up with three really important takeaways relative to 340B, which is a feat unto itself, considering how sprawling this conversation can be. So, if you came here fo…
  continue reading
 
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — FDA approves Illumina cancer biomarker test The bad — BioMarin reveals more layoffs The ugly — FDA hits API maker Global Calcium with 483Af Pharma Manufacturing
  continue reading
 
In this Summer Short Episode of Relentlessly Seeking Value, host Stacey Richter discusses the hidden costs and inefficiencies of value-based care with Elizabeth Mitchell, President and CEO of the Purchaser Business Group on Health (PBGH). To read the full article and show notes which include mentioned links, visit the episode page. If you enjoy thi…
  continue reading
 
OSF HealthCare stands as a model health system for those who want to do innovation right. One of the defining characteristics of the Peoria, Illinois-based system is how it aligns innovation with operations for everyone – all 24,000 employees across 159 locations, including 16 hospitals. Becky Buchen is responsible for driving innovation at OSF Hea…
  continue reading
 
The concept of healthspan has recently gained new attention in the pharma industry and rightfully so, given the surprisingly large chasm in the U.S. between average years lived (77.5) and average years lived in good health (63.9). Facing a growing demographic of unhealthy seniors, a handful of innovative biotechs are reframing the longevity discuss…
  continue reading
 
In this episode of HR Benecast, Mike Stull and Eric Dublikar cover your pharmacy and employee benefits questions including: What's new in federal and state pharmacy benefit legislation. How Employers Health is working to help clients manage changes to their PBM plans. What the switch to biosimilars for Humira and Stelara means for plan sponsors. Wh…
  continue reading
 
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Emergent donates 50,000 doses of mpox vaccine to Africa The bad — FDA rejects Regeneron blood cancer bispecific antibody The ugly — China indicts Astellas exec for espionage…
  continue reading
 
My conversation today is with Will Shrank, MD. Dr. Shrank led the evaluation group at CMMI (Center for Medicare and Medicaid Innovation). He has spent time in the private sector, first at CVS Health and UPMC (University of Pittsburgh Medical Center) as chief medical officer of the health plan in Pittsburgh, and then as the chief medical officer for…
  continue reading
 
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — FDA approves Ascendis hypoparathyroidism drug The bad — FDA rejects Lykos MDMA PTSD drug The ugly — Judge blocks Novartis bid to stop generic blockbuster heart drug…
  continue reading
 
George gave an incredible interview. He was so articulate of his journey and showed amazing resilience, inspitarion, vulnerability and real emotion. George was a real natural and I always say that the best interviews are the ones where i speak less and the interviewee speaks more. This epitomises that. George gave such detail about his story and is…
  continue reading
 
This encore episode is with Amy Scanlan, MD. It was, in fact, one of our most popular episodes of the past year. It is still just as relevant today in a slightly different way. It’s interesting how things which were said maybe a year ago have shades of meaning which become evident as time goes on. So, I liked this show a lot in the second listen wi…
  continue reading
 
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Amneal gets FDA nod for Parkinson’s pill The bad — Novo Nordisk withdraws bid for Wegovy label expansion in heart failure The ugly — FDA delays decision on BeiGene Tevimbra as a first-line therapy…
  continue reading
 
Join this month's PBM Reform cocktail crew as they discuss PBM exec lies during the recent Congressional hearing, the FTC Open Commission meeting, and why applying pressure at both the state and federal levels is so critical to getting real, enforceable reform across the finish line! Special Guest, Massachusetts pharmacy owner, Joe Chammas Opening …
  continue reading
 
In Episode 447, Stacey Richter interviews Ashleigh Gunter, president of Translucent Healthcare Consulting, to discuss the indispensable role of change management in healthcare transformation. They emphasize that creating an effective change strategy involves great leadership, a clear case for change, influential change champions, over-communication…
  continue reading
 
Many discount card programs are scams. Independent pharmacists can get burned when patients use these cards because they lose money. Al Branca works with Axe Rx and says that this program is different. This week Anthony talks with Al and he explains what makes Axe Rx different, how it can help you avoid audits, and why it's worth at least trying.…
  continue reading
 
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — FDA approves Adaptimmune engineered cell therapy The bad — FDA puts clinical hold on vTv Therapeutics diabetes program The ugly — Sanofi sues Sarepta over manufacturing patents for Duchenne gene ther…
  continue reading
 
In Episode 446, "Hey, Let's Not Talk About EHRs," host Stacey Richter engages Dr. Spencer Dorn, vice chair and professor of medicine at the University of North Carolina, in a comprehensive discussion about the implications of healthcare technology, specifically electronic health records (EHRs). Visit the Episode Page to read the show notes with men…
  continue reading
 
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — FDA approves Sun Pharma hair loss drug The bad — FDA issues harsh warning letter to Indian CDMO Brassica The ugly — EMA issues negative opinion on Eisai-Biogen Alzheimer's drug…
  continue reading
 
I wanted to talk with Dr. Lee because so many RHV (Relentless Health Value) listeners are trying to figure out how to sustain primary care as a stand-alone entity when the most obvious and most common way to make enough money in primary care is to drive and maximize the dollars from downstream volume of high-priced service lines, which, if you thin…
  continue reading
 
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Genentech's oral weight loss drug shows promise The bad — FDA denies accelerated approval for Agenus' cancer drug The ugly — Orexo's opioid overdose drug rejected again…
  continue reading
 
In this encore episode of 'Relentlessly Seeking Value,' host Stacey Richter revisits a critically important conversation with ERISA attorney Paul Holmes about the complexities and hidden pitfalls in Pharmacy Benefit Manager (PBM) contracts. Aimed at CFOs and employer plan sponsors, Holmes highlights how poorly reviewed PBM contracts can lead to com…
  continue reading
 
With great power comes great responsibility and in healthcare, those words may have never held more meaning than they do with the advent of artificial intelligence. AI most certainly has the power to transform healthcare, and those in the industry working to develop and use it have an immense responsibility to shape principles that ensure these tec…
  continue reading
 
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Pfizer advances once-daily obesity pill The bad — FDA rejects Novo Nordisk once-weekly insulin The ugly — FTC releases long-awaited report on PBMsAf Pharma Manufacturing
  continue reading
 
In Episode 444 of Relentless Health Value, Stacey Richter speaks with healthcare consultant Ann Kempski about two state healthcare laws with unintended consequences: the Certificate of Need (CON) and the Certificate of Public Advantage (COPA) laws. They delve into the original intentions behind these laws, the ways in which they have often failed, …
  continue reading
 
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — FDA grants Eli Lilly Alzheimer’s drug full approval The bad — FDA rejects Rocket gene therapy The ugly — Eisai, BMS end ADC partnershipAf Pharma Manufacturing
  continue reading
 
Join Lord Dr Jeremy and this month's cocktail crew as they discuss the importance of communication in advocacy, the newly released 3Axis report, and how PUTT is offering solutions to the PBM problem. Special Guests: pharmacy owners & PUTT Executive Board members Brandi Chane and Lauren Young Opening music by JuliusH Production & Editing by Shannon …
  continue reading
 
To read the full show notes with links mentioned, be sure to visit our episode page and consider signing up for our free weekly newsletter. Episode 443 of Relentless Health Value pays tribute to the late Marshall Allen, an investigative journalist dedicated to exposing injustices within the American healthcare system. Hosted by Stacey Richter, the …
  continue reading
 
By integrating a Quality by Design (QbD) approach, developers can design robust packaging from the outset, drastically reducing development time and costs. Understanding how moisture affects a product is key, allowing developers to use industry-accepted and validated models to predict and address potential stability issues early in the design phase…
  continue reading
 
This episode features Employers Health Chief Operating Officer, Zach Hostetler. He joins our Chief Sales Officer, Mike Stull to discuss pharmacy benefit rebate credits and why they exist. They'll cover how rebate credits are calculated, how long we can expect rebate credits to be around, how Employers Health is working to validate the value of the …
  continue reading
 
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Verona wins FDA nod for COPD The bad — FDA issues CRL to Merck-Daiichi lung cancer ADC The ugly — Glenmark recalls 114 batches of potassium chloride capsules…
  continue reading
 
In Episode 442 of 'Relentless Health Value,' host Stacey Richter shares an intriguing outtake from a previous episode featuring Andreas Mang, senior managing director at Blackstone, discussing the critical issue of cost management in oncology side effect treatment. The conversation delves into the inefficiencies and patient harms caused by inadequa…
  continue reading
 
Loading …

Hurtig referencevejledning